Introduction AROMA (NCT04959448) is a prospective global registry study that characterizes real-world use of dupilumab for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This analysis reports corticosteroid use and surgery history at baseline.
No takes yet. Share an insight, caveat, or question.
Wagenmann et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: